{"id":"https://openalex.org/W2042857405","doi":"https://doi.org/10.1159/000138472","title":"Anti-Ischaemic Activity of Various Calmodulin Antagonists","display_name":"Anti-Ischaemic Activity of Various Calmodulin Antagonists","publication_year":2008,"publication_date":"2008-06-05","ids":{"openalex":"https://openalex.org/W2042857405","doi":"https://doi.org/10.1159/000138472","mag":"2042857405","pmid":"https://pubmed.ncbi.nlm.nih.gov/3194443"},"language":"en","primary_location":{"id":"doi:10.1159/000138472","doi":"https://doi.org/10.1159/000138472","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000138472","pdf_url":null,"source":{"id":"https://openalex.org/S106137443","display_name":"Pharmacology","issn_l":"0031-7012","issn":["0031-7012","1423-0313"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111543056","display_name":"H. W. G. M. Boddeke","orcid":"https://orcid.org/0000-0002-5058-9648","observed_orcids":["https://orcid.org/0000-0002-5058-9648"]},"institutions":[{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"H.W.G.M. Boddeke","raw_affiliation_strings":["Division of Pharmacotherapy/Pharmacology, University of Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacotherapy/Pharmacology, University of Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I887064364"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091328827","display_name":"Bob Wilffert","orcid":"https://orcid.org/0000-0002-8759-5697","observed_orcids":["https://orcid.org/0000-0002-8759-5697"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"B. Wilffert","raw_affiliation_strings":["Division of Pharmacotherapy/Pharmacology, University of Amsterdam, Academic Medical Center, Amsterdam, The Netherlands","University of Amsterdam#N#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacotherapy/Pharmacology, University of Amsterdam, Academic Medical Center, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I887064364"]},{"raw_affiliation_string":"University of Amsterdam#N#","institution_ids":["https://openalex.org/I887064364"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041640238","display_name":"Jacqueline Geertruida Hugtenburg","orcid":"https://orcid.org/0000-0001-6098-2438","observed_orcids":["https://orcid.org/0000-0001-6098-2438"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"J.G. Hugtenburg","raw_affiliation_strings":["Division of Pharmacotherapy/Pharmacology, University of Amsterdam, Academic Medical Center, Amsterdam, The Netherlands","Clinical pharmacology and pharmacy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacotherapy/Pharmacology, University of Amsterdam, Academic Medical Center, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I887064364"]},{"raw_affiliation_string":"Clinical pharmacology and pharmacy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034700995","display_name":"T.J.W. Jap","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"T.J.W. Jap","raw_affiliation_strings":["Division of Pharmacotherapy/Pharmacology, University of Amsterdam, Academic Medical Center, Amsterdam, The Netherlands","University of Amsterdam#N#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacotherapy/Pharmacology, University of Amsterdam, Academic Medical Center, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I887064364"]},{"raw_affiliation_string":"University of Amsterdam#N#","institution_ids":["https://openalex.org/I887064364"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048920110","display_name":"Robin D. Veldsema-Currie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"R.D. Veldsema-Currie","raw_affiliation_strings":["University of Amsterdam#N#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Amsterdam#N#","institution_ids":["https://openalex.org/I887064364"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108214887","display_name":"Pieter A. van Zwieten","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"P.A. van Zwieten","raw_affiliation_strings":["Division of Pharmacotherapy/Pharmacology, University of Amsterdam, Academic Medical Center, Amsterdam, The Netherlands","University of Amsterdam#N#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacotherapy/Pharmacology, University of Amsterdam, Academic Medical Center, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I887064364"]},{"raw_affiliation_string":"University of Amsterdam#N#","institution_ids":["https://openalex.org/I887064364"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.20191151,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"37","issue":"4","first_page":"240","last_page":"247"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11057","display_name":"Cardiac Ischemia and Reperfusion","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11057","display_name":"Cardiac Ischemia and Reperfusion","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/calmodulin-antagonists","display_name":"calmodulin antagonists","score":0.9929999709129333},{"id":"https://openalex.org/keywords/myocardial-ischemia","display_name":"myocardial ischemia","score":0.8510000109672546},{"id":"https://openalex.org/keywords/felodipine","display_name":"felodipine","score":1.0},{"id":"https://openalex.org/keywords/w-7","display_name":"W-7","score":0.953000009059906},{"id":"https://openalex.org/keywords/calmidazolium","display_name":"calmidazolium","score":0.996999979019165},{"id":"https://openalex.org/keywords/calcium-channel-blockers","display_name":"calcium channel blockers","score":0.753000020980835},{"id":"https://openalex.org/keywords/ischemia-reperfusion-injury","display_name":"ischemia-reperfusion injury","score":0.6800000071525574},{"id":"https://openalex.org/keywords/cardiac-contractile-force","display_name":"cardiac contractile force","score":0.7120000123977661},{"id":"https://openalex.org/keywords/coronary-blood-flow","display_name":"coronary blood flow","score":0.7639999985694885},{"id":"https://openalex.org/keywords/atp","display_name":"ATP","score":0.3959999978542328},{"id":"https://openalex.org/keywords/phosphocreatine","display_name":"phosphocreatine","score":0.5870000123977661},{"id":"https://openalex.org/keywords/guinea-pig-heart","display_name":"guinea pig heart","score":0.6110000014305115}],"concepts":[{"id":"https://openalex.org/C2780648877","wikidata":"https://www.wikidata.org/wiki/Q420644","display_name":"Felodipine","level":3,"score":0.9314377903938293},{"id":"https://openalex.org/C29688787","wikidata":"https://www.wikidata.org/wiki/Q409145","display_name":"Calmodulin","level":3,"score":0.859686017036438},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.7104419469833374},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.4894494116306305},{"id":"https://openalex.org/C541997718","wikidata":"https://www.wikidata.org/wiki/Q188151","display_name":"Ischemia","level":2,"score":0.4712657928466797},{"id":"https://openalex.org/C2777383412","wikidata":"https://www.wikidata.org/wiki/Q4770891","display_name":"Antagonism","level":3,"score":0.45672115683555603},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4498242735862732},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4352726936340332},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.42721840739250183},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4010844826698303},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.39383596181869507},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.3377280831336975},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2212008237838745},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.06585362553596497}],"mesh":[{"descriptor_ui":"D000255","descriptor_name":"Adenosine Triphosphate","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002097","descriptor_name":"C-Reactive Protein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002147","descriptor_name":"Calmodulin","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D003326","descriptor_name":"Coronary Circulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003327","descriptor_name":"Coronary Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003327","descriptor_name":"Coronary Disease","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006168","descriptor_name":"Guinea Pigs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009200","descriptor_name":"Myocardial Contraction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015427","descriptor_name":"Reperfusion Injury","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015427","descriptor_name":"Reperfusion Injury","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1159/000138472","doi":"https://doi.org/10.1159/000138472","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000138472","pdf_url":null,"source":{"id":"https://openalex.org/S106137443","display_name":"Pharmacology","issn_l":"0031-7012","issn":["0031-7012","1423-0313"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology","raw_type":"journal-article"},{"id":"pmid:3194443","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3194443","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology","raw_type":"Journal Article"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/1feaa3da-e449-4d6d-8373-67a4ee87f66e","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/antiischaemic-activity-of-various-calmodulin-antagonists(1feaa3da-e449-4d6d-8373-67a4ee87f66e).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmacology, 37(4), 240 - 247. S. Karger AG","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/3814a1a9-94b0-4f4f-8926-7214b07baab3","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11370/3814a1a9-94b0-4f4f-8926-7214b07baab3","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BODDEKE, HWGM, WILFFERT, B, HUGTENBURG, JG, JAP, TJW, VELDSEMACURRIE, RD & VANZWIETEN, PA 1988, 'ANTI-ISCHAEMIC ACTIVITY OF VARIOUS CALMODULIN ANTAGONISTS', Pharmacology, vol. 37, no. 4, pp. 240-247.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/3814a1a9-94b0-4f4f-8926-7214b07baab3","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/3814a1a9-94b0-4f4f-8926-7214b07baab3","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmacology, 37(4), 240 - 247","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:vumc:oai:pure.atira.dk:publications/6082e5cc-fc1e-4ae6-be80-1213fac65e2b","doi":null,"is_oa":false,"landing_page_url":"https://research.vumc.nl/en/publications/6082e5cc-fc1e-4ae6-be80-1213fac65e2b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmacology, 37(4), 240 - 247. American Society for Pharmacology and Experimental Therapeutics","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2404830123","https://openalex.org/W2080014048","https://openalex.org/W2037506638","https://openalex.org/W2084826132","https://openalex.org/W2046934913","https://openalex.org/W2410637904","https://openalex.org/W19016550","https://openalex.org/W2037093009","https://openalex.org/W2315648584","https://openalex.org/W177766511"],"abstract_inverted_index":{"The":[0],"anti-ischaemic":[1,98,103,137],"activity":[2,104,120,138],"of":[3,30,37,62,87,102,105,121,139],"the":[4,80,84,88,106,115,136],"calmodulin":[5,109,131],"antagonists":[6],"trifluperazine,":[7,50],"felodipine,":[8],"W-7":[9],"and":[10,52,66,69,73,77,82,124],"calmidazolium":[11,95],"has":[12],"been":[13],"investigated":[14],"in":[15,46],"electrically":[16],"paced":[17],"guinea-pig":[18],"hearts,":[19],"perfused":[20],"according":[21],"to":[22,27,53,135],"Langendorff,":[23],"which":[24],"were":[25,58],"subjected":[26],"60":[28],"min":[29,36],"global":[31],"ischaemia":[32],"followed":[33],"by":[34],"30":[35],"reperfusion.":[38],"At":[39],"concentrations":[40],"that":[41,127],"induced":[42],"a":[43,54],"comparable":[44],"reduction":[45],"cardiac":[47],"contractile":[48],"force,":[49],"felodipine":[51,76,125],"lesser":[55],"extent":[56],"W-7,":[57],"associated":[59],"with":[60],"improvement":[61],"post-ischaemic":[63],"functional":[64],"(LVP":[65],"coronary":[67],"flow)":[68],"biochemical":[70],"parameters":[71],"(CrP":[72],"ATP).":[74],"Furthermore,":[75],"trifluperazine":[78,123],"delayed":[79],"onset":[81],"suppressed":[83],"maximum":[85],"tension":[86],"ischaemic":[89],"contracture":[90],"was":[91],"observed.":[92],"In":[93],"contrast,":[94],"had":[96],"no":[97],"effects.":[99],"This":[100],"lack":[101],"most":[107],"potent":[108],"antagonist":[110],"calmidazolium,":[111],"as":[112,114],"well":[113],"significant":[116],"calcium":[117],"entry":[118],"blocking":[119],"both":[122],"suggest":[126],"additional":[128],"factors":[129],"besides":[130],"antagonism":[132],"may":[133],"contribute":[134],"these":[140],"compounds.":[141]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}